• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从去纤苷中分离和鉴定在体外作为凝血酶拮抗剂的适体。

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro.

作者信息

Bracht F, Schrör K

机构信息

Institut für Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Germany.

出版信息

Biochem Biophys Res Commun. 1994 Apr 29;200(2):933-7. doi: 10.1006/bbrc.1994.1539.

DOI:10.1006/bbrc.1994.1539
PMID:8179629
Abstract

This study was designed to isolate and identify aptamer sequences, acting as thrombin antagonists, from defibrotide, a single-stranded DNA fraction. Two different aptamers were identified: 5'-GGTTGGATTGGTTGG-3' and 5'-GGTTGGATCGGTTGG-3'. A third aptamer: 5'-GGATGGATCGGTTGG-3' was found in the PCR product from the double-stranded defibrotide precursor. All aptamers were potent inhibitors of thrombin-induced platelet aggregation, thromboxane biosynthesis, increase in cytosolic Ca++ and fibrin clot formation, effective concentrations being in the nanomolar range. There was no effect on U 46,619 (thromboxane mimetic) or collagen-induced responses. Similar effects were obtained with unfractionated defibrotide while the "nonsense" oligonucleotide 5'-GGTGGTGGTTGTGGT-3' was inactive. The data suggest that antithrombin effects of defibrotide are caused by aptamers.

摘要

本研究旨在从单链DNA组分去纤苷中分离并鉴定作为凝血酶拮抗剂的适配体序列。鉴定出了两种不同的适配体:5'-GGTTGGATTGGTTGG-3'和5'-GGTTGGATCGGTTGG-3'。在双链去纤苷前体的PCR产物中发现了第三种适配体:5'-GGATGGATCGGTTGG-3'。所有适配体都是凝血酶诱导的血小板聚集、血栓素生物合成、胞质Ca++增加和纤维蛋白凝块形成的有效抑制剂,有效浓度在纳摩尔范围内。对U 46,619(血栓素模拟物)或胶原诱导的反应没有影响。未分级的去纤苷也获得了类似的效果,而“无义”寡核苷酸5'-GGTGGTGGTTGTGGT-3'没有活性。数据表明去纤苷的抗凝血酶作用是由适配体引起的。

相似文献

1
Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro.从去纤苷中分离和鉴定在体外作为凝血酶拮抗剂的适体。
Biochem Biophys Res Commun. 1994 Apr 29;200(2):933-7. doi: 10.1006/bbrc.1994.1539.
2
Isolation and functional characterization of DNA-derived aptamers that act as thrombin inhibitors in human platelets and coagulation assays.在人血小板和凝血检测中作为凝血酶抑制剂的DNA衍生适配体的分离及功能表征。
Agents Actions Suppl. 1995;45:315-22. doi: 10.1007/978-3-0348-7346-8_43.
3
Selection of single-stranded DNA molecules that bind and inhibit human thrombin.结合并抑制人凝血酶的单链DNA分子的筛选。
Nature. 1992 Feb 6;355(6360):564-6. doi: 10.1038/355564a0.
4
Thrombin inhibitors based on single-stranded DNA aptamers.基于单链DNA适配体的凝血酶抑制剂。
Blood Coagul Fibrinolysis. 2014 Jan;25(1):39-45. doi: 10.1097/MBC.0b013e32836577f3.
5
Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.纤溶酶原激活剂和抗血小板药物联合作用下,富含血小板的纤维蛋白凝块在体外的快速溶解
J Pharmacol Exp Ther. 1991 Dec;259(3):1371-8.
6
2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.2-(2-溴苯基)-8-甲氧基苯并恶唑啉酮(HPW-RX2),一种对血小板中血栓素形成具有抑制作用的直接凝血酶抑制剂。
Eur J Pharmacol. 2005 Dec 19;527(1-3):37-43. doi: 10.1016/j.ejphar.2005.10.023. Epub 2005 Nov 28.
7
Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.结合不同表位的人凝血酶的寡核苷酸抑制剂。
J Mol Biol. 1997 Oct 10;272(5):688-98. doi: 10.1006/jmbi.1997.1275.
8
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.去纤苷对小鼠和家兔肺血管以及家兔脑血管中血栓栓塞的影响。
Br J Pharmacol. 1993 Dec;110(4):1565-71. doi: 10.1111/j.1476-5381.1993.tb14002.x.
9
Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.用纤溶酶对人血小板进行预处理可抑制对凝血酶的反应,但会增强对低浓度聚集剂(包括凝血酶受体激活肽SFLLRN)的反应。
Thromb Haemost. 1997 Apr;77(4):741-7.
10
Effect of defibrotide on platelet function.去纤苷对血小板功能的影响。
Semin Thromb Hemost. 1996;22 Suppl 1:21-4.

引用本文的文献

1
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide.靶向肠道通透性治疗移植物抗宿主病:去纤苷的治疗前景
J Exp Pharmacol. 2025 Sep 4;17:613-623. doi: 10.2147/JEP.S534739. eCollection 2025.
2
The RNA revolution in medicine: from gene regulation to clinical therapeutics.医学中的RNA革命:从基因调控到临床治疗
Anim Cells Syst (Seoul). 2025 Aug 25;29(1):523-543. doi: 10.1080/19768354.2025.2548253. eCollection 2025.
3
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients.
地塞米松对儿童造血干细胞移植受者急性移植物抗宿主病发病率的影响。
Life Sci Alliance. 2023 Mar 6;6(5). doi: 10.26508/lsa.202201786. Print 2023 May.
4
The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae.内皮保护的重要性:地塞米松在逆转内皮损伤及其后果中的新作用。
Bone Marrow Transplant. 2021 Dec;56(12):2889-2896. doi: 10.1038/s41409-021-01383-x. Epub 2021 Sep 28.
5
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.多阴离子药物 defibrotide 的内皮保护、组蛋白中和特性。
JCI Insight. 2021 Sep 8;6(17):e149149. doi: 10.1172/jci.insight.149149.
6
Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.地夫可特可抑制供者白细胞与内皮细胞的相互作用,并可预防急性移植物抗宿主病。
J Cell Mol Med. 2020 Jul;24(14):8031-8044. doi: 10.1111/jcmm.15434. Epub 2020 Jun 10.
7
The use of defibrotide in blood and marrow transplantation.在血液和骨髓移植中使用地夫可特。
Blood Adv. 2018 Jun 26;2(12):1495-1509. doi: 10.1182/bloodadvances.2017008375.
8
Defibrotide in the treatment of hepatic veno-occlusive disease.去纤苷治疗肝静脉闭塞性疾病
Hepat Med. 2016 Oct 31;8:105-113. doi: 10.2147/HMER.S79243. eCollection 2016.
9
Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.造血干细胞移植患者肝静脉闭塞病的预防干预措施。
Cochrane Database Syst Rev. 2015 May 27;2015(5):CD009311. doi: 10.1002/14651858.CD009311.pub2.
10
Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.去纤苷:造血干细胞移植后用于严重肝静脉闭塞病的应用综述
Clin Drug Investig. 2014 Dec;34(12):895-904. doi: 10.1007/s40261-014-0242-x.